Coating Place Inc.
- Company typePrivate
- Founded1976
- HeadquartersVerona, United States
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
Coating Place Inc. firmographics
Firmographics- Name
- Coating Place Inc.
- Legal name
- Coating Place, Inc.
- Website
- https://coatingplace.com
- Company type
- Private
- Founded year
- 1976
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Ownership category
- akta.pro rank
Coating Place Inc. industry classification
Industry- Product category
- Pharmaceutical Contract Manufacturing (CDMO)
- NAICS
- Paint, Coating, and Adhesive Manufacturing (3255)
- SIC
- Coating, Engraving & Allied Services (3470)
- akta.pro primary industry
- Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)
- akta.pro secondary industry
- Packaging, Labeling & Serialization (Clinical/Commercial) CDMO (HLAGABAJ)
Keywords
Where Coating Place Inc. is headquartered
LocationHeadquarters
- HQ city
- Verona
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Coating Place Inc. business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales, Others
Revenue model
- CDMO Contract Manufacturing Services: Coating Place operates as a contract development and manufacturing organization providing fee-for-service work encompassing formulation development, technology transfer, process scale-up, and commercial manufacturing. Services are project-based with custom quotations depending on scope, batch size, and complexity. The company has supported the approval of more than 23 NDA/ANDA products.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom project-based pricing |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Coating Place Inc. product offering
Product offeringCore offering
Coating Place Inc. is a pharmaceutical contract development and manufacturing organization (CDMO) specializing in Wurster fluid bed microencapsulation technology. The company provides formulation development, process scale-up, technology transfer, validation, and commercial manufacturing of coated particles, granules, and dosage forms for pharmaceutical, nutraceutical, animal health, and industrial clients. Its branded offerings include the Oradel® oral delivery coating platform and the Encap™ line of microencapsulated products for industrial markets.
Product overview
Coating Place Inc. is a Contract Development and Manufacturing Organization (CDMO) specializing in proprietary Wurster fluid bed microencapsulation technology. The company's core offering is the Oradel® platform—a comprehensive oral delivery coating system comprising five distinct technologies (Multilayer Coating, Extended Release, Delayed Release, Enteric Coating, and Ion Resin Technology) that can be used individually or combined for customized drug release profiles. Complementing this is the Encap™ product line serving industrial oil and gas markets with encapsulated breakers for hydraulic fracturing. The company provides full-service CDMO capabilities including formulation development, tech transfer, process scale-up, process validation, particle engineering, analytical lab services, and dosage form manufacturing (capsules, tablets, pellets, bulk powder). Operations span pharmaceutical, nutraceutical, animal health, and specialty chemical end markets across two FDA-registered and DEA-licensed facilities totaling over 350,000 sq ft.
Differentiator
Problem solved
Functional benefit
Brands
- Oradel®: Proprietary platform of oral delivery coating techniques including multilayer coating, extended release, delayed release, enteric coating, and ion resin technology.
- Encap™
Products and services
- Oradel® Oral Delivery Coating Platform
- Encap™ Microencapsulated Product Line
- Wurster Fluid Bed Coating Services
- Abuse-Deterrent Formulation Solutions Development and manufacturing services for abuse-deterrent opioid and CNS drug formulations, leveraging Wurster coating and particle engineering to meet FDA guidance on tamper-resistant dosage forms.
- Technology Transfer Services End-to-end technology transfer of client-developed processes from R&D or pilot scales into Coating Place's commercial manufacturing facilities, including documentation, scale-up bridging, and regulatory support.
- Process Scale-Up Services Scale-up of Wurster coating and related processes from laboratory (0.01 kg) through pilot to commercial (800 kg) batch sizes using the company's FDA-recognized linear scalability methodology.
- Process Validation Services Process performance qualification (PPQ) and validation support for commercial Wurster coating and encapsulation batches, including execution of validation protocols and regulatory documentation.
- Particle Engineering Services Custom particle engineering using high-shear granulation, fluid bed granulation, extrusion, and spheronization to engineer particle size, density, morphology, and release characteristics for client APIs.
- Analytical Laboratory Services In-house analytical testing supporting coating development and GMP release, including assay, content uniformity, dissolution testing, particle size analysis, and stability support.
- Dosage Form Manufacturing Services Finished dosage form manufacturing of coated oral solid dose products, including DEA-licensed handling of Schedule I-V controlled substances, for pharmaceutical commercial supply.
Quantifiable outcome
- Supported approval of 23+ NDA/ANDA products
- +2 more outcomes
Companies that use Coating Place Inc.
Customer profileSegments4 records
Ideal customer profiles4 records
Coating Place Inc. technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature10 records
Coating Place Inc. partnerships and signals
Strategic signalScale indicators6 records
Recent moves11 records
Expansion highlights5 records
Coating Place Inc. competitors and assessment
Company assessmentBroad incumbents
- Eurofins CDMO (formerly Bend Research): Pharmaceutical CDMO with particle engineering, formulation development, and oral dosage capabilities. Comparable in offering development and GMP manufacturing services to pharma sponsors.
- Catalent Pharma Solutions: Large-scale global CDMO with overlapping oral solid dose, softgel, and controlled-release capabilities. A broad incumbent in the same pharma outsourcing space that Coating Place serves.
- Lonza Group: Global CDMO with pharma oral solid dose capabilities alongside biologics. A broad incumbent that competes for outsourced pharmaceutical manufacturing contracts globally.
- Aenova Group: European-headquartered pharmaceutical CDMO with strong oral solid dose capabilities. A broad incumbent that competes for similar oral solid dose CDMO work, though geographically concentrated in Europe.
- Patheon (Thermo Fisher Scientific): Global pharma services/CDMO platform under Thermo Fisher with extensive oral solid dose, API, and biologics manufacturing. Competes for the same CDMO contracts as Coating Place at significantly larger scale.
- Cambrex: Small-molecule API and finished dosage CDMO serving global pharma. A broad incumbent competing for similar pharmaceutical contract manufacturing work.
Direct peers
- Glatt Pharmaceutical Services: Operates fluid bed and Wurster coating technology for pharmaceutical applications, directly competing with Coating Place's core Wurster process technology and oral solid dose CDMO offering.
- Adare Pharma Solutions: CDMO specializing in oral solid dosage forms including taste masking, controlled release, and complex formulation. Directly comparable to Coating Place's Oradel® platform and pharma customer base.
Emerging players
- Hovione: CDMO specializing in particle engineering, spray drying, and oral dosage form development. Overlaps with Coating Place's particle engineering, scale-up, and controlled-release capabilities for pharma sponsors.
- Ascendia Pharmaceuticals: Specialty CDMO focused on complex and poorly soluble formulations including nanoemulsions, amorphous dispersions, and oral controlled-release dosage forms. Comparable emerging player targeting similar pharma outsourcing customers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Coating Place Inc. social profiles
Digital presenceCoating Place Inc. compliance and trust
Trust signalCompliance9 records
Coating Place Inc. financial estimates
Financial estimateRevenue estimate
Valuation estimate
Coating Place Inc. leadership team
Management profileNumber of profiles
Profiles8 records
Coating Place Inc. funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Coating Place Inc. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Coating Place Inc.
What does Coating Place Inc. do?
Coating Place Inc. is a pharmaceutical contract development and manufacturing organization (CDMO) specializing in Wurster fluid bed microencapsulation technology. The company provides formulation development, process scale-up, technology transfer, validation, and commercial manufacturing of coated particles, granules, and dosage forms for pharmaceutical, nutraceutical, animal health, and industrial clients. Its branded offerings include the Oradel® oral delivery coating platform and the Encap™ line of microencapsulated products for industrial markets.
Is Coating Place Inc. a public or private company?
Coating Place Inc. is a private company. It is classified as family owned and is currently operating.
When was Coating Place Inc. founded?
Coating Place Inc. was founded in 1976. It employs 251 to 500 people.
Where is Coating Place Inc. based?
Coating Place Inc. is headquartered in Verona, United States, in the North America region.
How does Coating Place Inc. make money?
One revenue line is on record: CDMO Contract Manufacturing Services.
Who are Coating Place Inc.'s main competitors?
Broad incumbents on record are Eurofins CDMO (formerly Bend Research), Catalent Pharma Solutions, Lonza Group, Aenova Group, Patheon (Thermo Fisher Scientific) and Cambrex. Direct peers are Glatt Pharmaceutical Services and Adare Pharma Solutions. Emerging players are Hovione and Ascendia Pharmaceuticals.
Does Coating Place Inc. have an API?
No public API is recorded for Coating Place Inc..
What industry is Coating Place Inc. in?
Coating Place Inc.'s product category is Pharmaceutical Contract Manufacturing (CDMO). Its primary akta.pro industry code is HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO, with a secondary code of HLAGABAJ, Packaging, Labeling & Serialization (Clinical/Commercial) CDMO. Its NAICS code is 3255 and its SIC code is 3470.